Manufacturer record
Mankind Pharma Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Mankind Pharma Ltd (Sikkim) were declared Not of Standard Quality between September 2023 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: B95Z020, L-Carnitine L-Tartrate, Mecobalamin & Folic Acid Tablets (exp Jan 2028). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample gave identity test Negative for Mecobalamin & Folic Acid, Hence spurious. Listed in the September 2026 alert.
Records by type
5 records linked to Mankind Pharma Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| L-Carnitine L-Tartrate, Mecobalamin & Folic Acid Tablets | Batch B95Z020Mfg Feb 2026 · Exp Jan 2028 | The sample gave identity test Negative for Mecobalamin & Folic Acid, Hence spuriousSpurious | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| L-Carnitine L-Tartrate, Mecobalamin & Folic Acid Tablets | Batch B95Y032Mfg Mar 2025 · Exp Feb 2027 | The sample gives Negative Identity test for Mecobalamin & Folic Acid, Hence the sample is SpuriouOther | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Amlodipine & Atenolol Tablets IP | Batch G65Y010Mfg Jan 2025 · Exp Dec 2026 | The sample does not conform to I.P. w.r.to the tests for Identification and AssayAssay | SDTL, GuwahatiState lab | Jun 2026 |
| Telmisartan & Hydrochlorothizide Tablets IP | Batch B25X021Mfg Dec 2024 · Exp Nov 2026 | test for Dissolution of Telmisartan onlyDissolution | RDTL, Hubli, KarnatakaState lab | Nov 2025 |
| Rabeprazole Gastro- Resistant Tablets I.P. (RABEKIND-20) | Batch H2IAV013Mfg Nov 2022 · Exp Oct 2024 | Dissolution of Rabeprazole Sodium in Acid PhaseDissolution | RDTL GuwahatiState lab | Sep 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.